Liothyronine Sodium
- Product NDC
- 51862-320
- 11-digit product format
- 518620320
- Labeler code
- 51862
- Product ID
- 51862-320_be3f7994-e226-4c95-9749-2c33a95e2da8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Liothyronine Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Mayne Pharma
- Application
- ANDA090097
- Marketing category
- ANDA
- Marketing start
- 2018-01-01
- Marketing end
- 0000-00-00
- Substance
- LIOTHYRONINE SODIUM
- Active strength
- 5 ug/1
- Pharmacologic classes
- l-Triiodothyronine [EPC],Triiodothyronine [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51862-320 | LIOTHYRONINE SODIUM TABLET [MAYNE PHARMA COMMERCIAL LLC] | 3 | Legacy NDC | 20230707_03ca9e2a-5a27-43ff-a1cd-9c617a415b62.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51862-320-01 | 51862032001 | 100 TABLET in 1 BOTTLE, PLASTIC (51862-320-01) | 100 tablet | 2018-01-01 | 0000-00-00 | No | No | Current |